Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities—2017 Update
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
This report describes the outcomes of a process undertaken to review and update the National Safety Council's Alcohol, Drugs and Impairment Division's recommendations for the toxicological investigation of suspected alcohol and drug-impaired driving cases and motor vehicle fatalities. The updates to the recommendations are made based on a survey of practices in laboratories in the USA and Canada performing testing in these cases, consideration of existing epidemiological crash and arrest data, current drug use patterns, and practical considerations of widely available technology platforms in laboratories performing this work. The final recommendations updates are derived from a consensus meeting of experts recruited from survey respondents and the membership of the National Safety Council's Alcohol, Drug and Impairment Division. The principal changes in this round of recommendations include removal of butalbital, phenobarbital, and phencyclidine from Tier I (mandatory) to Tier II (optional) due to changes in prevalence. In addition, buprenorphine, fentanyl, tramadol, and their metabolites were moved from Tier II to Tier I due to increased prevalence and concerns about their potential for causing impairment. In addition, screening and confirmatory cutoffs for the oral fluid scope were further refined. Other additions were made to the list of Tier II compounds including fentanyl analogs (e.g., acetylfentanyl, butyrylfentanyl, furanylfentanyl, etc), mitragynine, novel opioids (e.g., MT-45, U-47700), atypical antipsychotics, and novel benzodiazepines (e.g., clonazolam, flubromazolam, etc).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the rise in HRMS use in screening from 2017 to 2021 demonstrates the shift toward broad, mass spectral-based screening methods.”
From Evaluation of enzyme-linked immunosorbent assay screening kits for the detection of nitazene analogs (2025) · cites this paper as [19]
Citations
Cites
Strengthening Forensic Science in the United States: A Path Forward
Council, N. R. (2009) · CrimRxiv · doi:10.21428/cb6ab371.b2d683d2 · Cited by 1,461
Strengthening forensic science in the United States : a path forward
Policy, L. (2009) · National Academies Press eBooks · Cited by 964
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review
Logan, B. K., Mohr, A. L. A., Friscia, M., Krotulski, A. J., Papsun, D. M., Kacinko, S. L., Ropero-Miller, J. D., & Huestis, M. A. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx031 · Cited by 166 · cited 1×
“These include compounds such as the synthetic cannabinoids, cathinones and “bath salts”, and novel opioids, especially analogs (4, 5).”
BackgroundSelf-citationNon-Smoker Exposure to Secondhand Cannabis Smoke. I. Urine Screening and Confirmation Results
Cone, E. J., Bigelow, G. E., Herrmann, E. S., Mitchell, J. M., LoDico, C., Flegel, R., & Vandrey, R. (2015) · Journal of Analytical Toxicology · doi:10.1093/jat/bku116 · Cited by 85 · cited 1×
“There was some discussion about the possibility of raising the urine screening and confirmation thresholds to concentrations that would rule out the possibility of passive exposure (6).”
BackgroundMoore, C. M., Rana, S., & Coulter, C. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.12.008 · Cited by 66 · cited 1×
“Tramadol and its metabolite O-desmethyltramadol were added with recommended screening and confirmation cutoffs for tramadol of 50 and 10 ng/mL respectively in oral fluid (7).”
BackgroundRecommendations for Toxicological Investigation of Drug Impaired Driving*
Farrell, L. J., Kerrigan, S., & Logan, B. K. (2007) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2007.00516.x · Cited by 61 · cited 1×
“Based on the results of the survey and consensus input from a subsequent face-to-face meeting of a panel of forensic toxicologists, the first recommendations document was published in 2007, and represents a list of drugs which ought to be tested for in suspected impaired driving cases (1).”
BackgroundSelf-citationLogan, B. K., Lowrie, K. J., Turri, J. L., Yeakel, J. K., Limoges, J. F., Miles, A. K., Scarneo, C. E., Kerrigan, S., & Farrell, L. J. (2013) · Journal of Analytical Toxicology · doi:10.1093/jat/bkt059 · Cited by 53 · cited 2×
“The 2013 recommendations listed 50 Tier II compounds that may be emerging, or have regional but not national prevalence in DUID populations (3).”
BackgroundMethodSelf-citationDavies, B., Bayard, C., Larson, S. J., Zarwell, L. W., & Mitchell, R. A. (2015) · Journal of Analytical Toxicology · doi:10.1093/jat/bkv136 · Cited by 22 · cited 1×
“These include compounds such as the synthetic cannabinoids, cathinones and “bath salts”, and novel opioids, especially analogs (4, 5).”
Background
Cited by
Interpreting γ-hydroxybutyrate concentrations for clinical and forensic purposes
Busardò, F. P., & Jones, A. W. (2018) · Clinical Toxicology · doi:10.1080/15563650.2018.1519194 · Cited by 86
“However, obtaining samples of saliva is less invasive than drawing blood, which makes this fluid more convenient for off-site testing, such as drug screening in various populations, such as motorists [83,84].”
BackgroundAlsenedi, K. A., & Morrison, C. (2018) · Analytical Methods · doi:10.1039/c8ay00041g · Cited by 75
The Role of Mass Spectrometry in the Cannabis Industry
Nie, B., Henion, J. D., & Ryona, I. (2019) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-019-02164-z · Cited by 65
“The topic of driving under the influence of drugs (DUID) raises increasing concerns by authorities such as the National Safety Council’s Alcohol, Drugs and Impairment Division (NSC-ADID) [38] and theNational HighwayTransportation Safety Administration (NHTSA) [39] as well as the general public.”
BackgroundD’Orazio, A. L., Mohr, A. L. A., Chan-Hosokawa, A., Harper, C., Huestis, M. A., Limoges, J. F., Miles, A. K., Scarneo, C. E., Kerrigan, S., Liddicoat, L. J., et al. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab064 · Cited by 60
“The updated recommendations were published in 2018 (6).”
BackgroundSelf-citationAzofeifa, A., Rexach-Guzmán, B. D., Hagemeyer, A. N., Rudd, R. A., & Sauber‐Schatz, E. K. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6850a1 · Cited by 57
“In addition, adoption and application of standards for toxicology testing and support for laboratories to implement recommendations are needed to improve understanding of the prevalence of drug- and polysubstance-impaired driving (10).”
BackgroundTramadol use and public health consequences in Iran: a systematic review and meta‐analysis
Abadi, Y. R., Gholami, J., Amin‐Esmaeili, M., Safarcherati, A., Mojtabai, R., Ghadirzadeh, M. R., Rahimi, H., & Rahimi‐Movaghar, A. (2020) · Addiction · doi:10.1111/add.15059 · Cited by 54
Kahl, K. W., Seither, J. Z., & Reidy, L. J. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz066 · Cited by 49
Driving under the influence of drugs
Marillier, M., & Verstraete, A. (2019) · Wiley Interdisciplinary Reviews Forensic Science · doi:10.1002/wfs2.1326 · Cited by 46
Sofalvi, S., Lavins, E. S., Naso-Kaspar, C. K., Michel, H. M., Mitchell-Mata, C. L., Huestis, M. A., & Apollonio, L. G. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa072 · Cited by 41
Self-citationA Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC–MS-MS
Farley, M., Tran, H., Towler, S., Gevorkyan, J., Pearring, S., & Rodda, L. N. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab075 · Cited by 40
Palmquist, K. B., Truver, M. T., Shoff, E. N., Krotulski, A. J., & Swortwood, M. J. (2023) · Journal of Forensic Sciences · doi:10.1111/1556-4029.15282 · Cited by 39
“5 μg/L screening/ confirmation cutoff for blood, urine, and oral fluid) and fentanyl analogs and novel opioids were added to Tier II due to increasing prevalence [4].”
MethodTruver, M. T., & Swortwood, M. J. (2018) · Journal of Analytical Toxicology · doi:10.1093/jat/bky053 · Cited by 35
Pelletti, G., Verstraete, A., Reyns, T., Barone, R., Rossi, F., Garagnani, M., & Pelotti, S. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.109914 · Cited by 34
On-site testing of multiple drugs of abuse in urine by a miniature dual-LIT mass spectrometer
Kang, M., Zhang, W., Dong, L., Ren, X., Zhu, Y., Wang, Z., Liang, L., Xue, J., Zhang, Y., Zhang, W., et al. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.12.028 · Cited by 33
Krotulski, A. J., Mohr, A. L. A., Friscia, M., & Logan, B. K. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx105 · Cited by 32
Self-citationBarone, R., Pelletti, G., Garagnani, M., Giusti, A., Marzi, M., Rossi, F., Roffi, R., Fais, P., & Pelotti, S. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.110004 · Cited by 30
Fentanyl and Driving Impairment
Rohrig, T. P., Nash, E., Osawa, K. A., Shan, X., Scarneo, C. E., Youso, K. B., Miller, R., & Tiscione, N. B. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa105 · Cited by 28
Self-citationTHC and CBD blood and brain concentrations following daily administration to adolescent primates
Withey, S. L., Bergman, J., Huestis, M. A., George, S. R., & Madras, B. K. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108129 · Cited by 29
Self-citationDetection of drugs in simultaneously collected samples of oral fluid and blood
Bakke, E., Høiseth, G., Arnestad, M., & Gjerde, H. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bky079 · Cited by 25
Vincenti, F., Montesano, C., Pirau, S., Gregori, A., Rosa, F. D., Curini, R., & Sergi, M. (2021) · Molecules · doi:10.3390/molecules26195870 · Cited by 25
“As a consequence, fentanyl detection has increased not only in seized drugs and postmortem specimens but also on the roadside [3,4].”
BackgroundPapsun, D. M., Chan‐Hosokawa, A., Lamb, M. E., & Logan, B. K. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkad036 · Cited by 25
Self-citationA threshold LC–MS/MS method for 92 analytes in oral fluid collected with the Quantisal® device
Desharnais, B., Lajoie, M.-J., Laquerre, J., Mireault, P., & Skinner, C. D. (2020) · Forensic Science International · doi:10.1016/j.forsciint.2020.110506 · Cited by 26
Quantification of fentanyl analogs in oral fluid using LC‐QTOF‐MS
Palmquist, K. B., & Swortwood, M. J. (2021) · Journal of Forensic Sciences · doi:10.1111/1556-4029.14813 · Cited by 20
“However, fentanyl concentrations in the samples were detectable above cutoff values defined by the NSC and Redwood Toxicology (1 ng/ mL) (3, 27).”
BackgroundMethodInfluentialImmunoassay-based detection of fentanyl analogs in forensic toxicology
Schackmuth, M., & Kerrigan, S. (2018) · Forensic Toxicology · doi:10.1007/s11419-018-0445-6 · Cited by 19
Self-citationNovel and Nonroutine Benzodiazepines and Suvorexant by LC–MS-MS
Garcia, L., Tiscione, N. B., Yeatman, D. T., & Richards‐Waugh, L. L. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa109 · Cited by 18
Pelletti, G., Garagnani, M., Rossi, F., Roffi, R., Barone, R., & Pelotti, S. (2018) · Forensic Science International · doi:10.1016/j.forsciint.2018.10.023 · Cited by 17
Ayala, J., & Kerrigan, S. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkad069 · Cited by 16
Self-citationPelletti, G., Rossi, F., Garagnani, M., Barone, R., Roffi, R., Fais, P., & Pelotti, S. (2020) · Forensic Science International · doi:10.1016/j.forsciint.2020.110291 · Cited by 16
Mata, D. C., & Davis, J. F. (2022) · Forensic Science International · doi:10.1016/j.forsciint.2022.111246 · Cited by 15
Development of a Reliable Method for Assessing Coca Alkaloids in Oral Fluid by HPLC–MS-MS
Rubio, N. C., Bermejo‐Barrera, P., Bermejo, A. M., & Moreda‐Piñeiro, A. (2018) · Journal of Analytical Toxicology · doi:10.1093/jat/bky076 · Cited by 14
Gabapentin in drugged driving investigations
Bierly, J. J., & Chan‐Hosokawa, A. (2024) · Journal of Forensic Sciences · doi:10.1111/1556-4029.15500 · Cited by 13
“The number of forensic toxicology laboratories reporting gabapentin in their 15 most frequently de - tected compounds increased from five in 2017 to 21 in 2021 in the National Safety Council Alcohol, Drugs, and Impairment Division (NSC-ADID) survey [2, 3].”
BackgroundAccioni, F., Nieddu, M., Corona, P., & Boatto, G. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz039 · Cited by 13
Fentanyl, Acetylfentanyl and Carfentanil in Impaired Driving Cases: A Review of 270 Cases
Kiely, E., & Juhascik, M. P. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab085 · Cited by 13
The impact of fentanyl on DUIDs and traffic fatalities: Blood and oral fluid data
Harper, C. E., Mata, D. C., & Lee, D. (2023) · Journal of Forensic Sciences · doi:10.1111/1556-4029.15334 · Cited by 13
Abbott, D. L., Limoges, J. F., Virkler, K. J., Tracy, S. J., & Sarris, G. G. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab033 · Cited by 13
Self-citationOral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations
Truver, M. T., Palmquist, K. B., & Swortwood, M. J. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz075 · Cited by 13
Havro, V., Casassa, N., Andera, K. M., & Mata, D. C. (2022) · Journal of Analytical Toxicology · doi:10.1093/jat/bkac030 · Cited by 12
Recent progress in the application of chemical attribution in forensic profiles
Zhang, Z., Wang, J., Lu, X., & Wang, H. (2024) · Forensic Chemistry · doi:10.1016/j.forc.2024.100556 · Cited by 12
Screening for Forensically Relevant Drugs Using Data-Independent High-Resolution Mass Spectrometry
Bates, M. N., Helm, A. E., & Barkholtz, H. M. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00379 · Cited by 12
Ropero‐Miller, J. D., Mullen, L. D., & Speaker, P. J. (2022) · Forensic Science International Synergy · doi:10.1016/j.fsisyn.2022.100292 · Cited by 13
Benzodiazepines in the oral fluid of Spanish drivers
Herrera‐Gómez, F., García-Mingo, M., & Alvarez, E. (2020) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-020-00260-y · Cited by 13
Marti, M., Bilel, S., Giorgetti, A., Tirri, M., Arfè, R., Cristofori, V., Marchetti, B., Corli, G., Caruso, L., Zauli, G., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666221116160032 · Cited by 11
Tsai, J., Yang, Y., Ho, P., Wu, T.-N., Guo, Y. L., Chen, P., & Chuang, H. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.849547 · Cited by 11
Toxicological and Demographic Profiles of Phencyclidine-Impaired Driving Cases in Houston
Lee, D., & Stout, P. R. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz111 · Cited by 10
Evaluation of enzyme-linked immunosorbent assay screening kits for the detection of nitazene analogs
Pacana, A. L., & Skillman, B. N. (2025) · Journal of Forensic Sciences · doi:10.1111/1556-4029.70052 · Cited by 9
“Conversely, the 2021 study reported 23% of laboratories employed high-resolution mass spectrometry (HRMS) screening methods, an increase from 11% in 2017 [19, 20].”
Behnke, G., Tiscione, N. B., Rakus, J. F., & Richards‐Waugh, L. L. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz010 · Cited by 9
Glicksberg, L., & Casey, B. K. (2022) · Journal of Analytical Toxicology · doi:10.1093/jat/bkac035 · Cited by 8
D’Orazio, A. L., Mohr, A. L. A., Chan‐Hosokawa, A., Harper, C. E., Huestis, M. A., Kerrigan, S., Limoges, J. F., Miles, A., Scarneo, C. E., Scott, K. S., et al. (2025) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaf085 · Cited by 7
Self-citationÁlvarez-Freire, I., Cabarcos-Fernández, P., Rubio, N. C., Moreda‐Piñeiro, A., Tabernero, M. J., Sánchez‐Sellero, I., Bermejo‐Barrera, P., & Bermejo, A. M. (2023) · Analytical Methods · doi:10.1039/d3ay01298k · Cited by 7
A Review on the Impact of Cannabis in Society and the Analytical Methodologies for Cannabinoids
Vergne, M. J., Reynolds, L. J., Brown, A., Pullias, G., & Froemming, A. (2023) · Psychoactives · doi:10.3390/psychoactives2010003 · Cited by 7
“The investigation of driving under the influence of drugs (DUID) is of increasing concern by law enforcement and the general public [74,75].”
BackgroundCabarcos-Fernández, P., Álvarez-Freire, I., Rubio, N. C., Bermejo, A. M., Moreda‐Piñeiro, A., Sánchez‐Sellero, I., & Tabernero, M. J. (2024) · Molecules · doi:10.3390/molecules29030592 · Cited by 6
“…can be detectable within the same time window wherein COC is detectable, which implies that HYG and CUS should not be lower than the LOD before the COC concentrations were below the COC cut-off values established by international guidelines for oral fluid (8 ng/mL or lower in DUID and WDT) [11,12].”
MethodBupenorphine in Wisconsin Drivers: Concerns for Impairment?
Edwards, L. D. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz068 · Cited by 6
Buprenorphine Prevalence in DUID Cases in Southwestern Virginia: Case Studies and Observations
Kuhlman, J. J., Harris, C., & Wright, T. H. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa176 · Cited by 4
LeBeau, M. A., Harper, C. E., Johnson, R. D., Kahl, J. H., & Reidy, L. J. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab120 · Cited by 4
D’Orazio, A. L., Mohr, A. L. A., Chan‐Hosokawa, A., Harper, C. E., Huestis, M. A., Kerrigan, S., Limoges, J. F., Miles, A., Scarneo, C. E., Scott, K. S., et al. (2025) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaf029 · Cited by 3
Self-citationRubio, N. C., Herbello-Hermelo, P., Álvarez-Freire, I., Cabarcos-Fernández, P., Tabernero, M. J., Sánchez‐Sellero, I., Bermejo‐Barrera, P., Bermejo, A. M., & Moreda‐Piñeiro, A. (2025) · Forensic Science International · doi:10.1016/j.forsciint.2025.112494 · Cited by 3
Driving Under the Influence of Drugs: When the Law Misses the Mark
Tiscione, N. B., Alford, I., Miller, R., Shan, X., & Yeatman, D. T. (2018) · Journal of Analytical Toxicology · doi:10.1093/jat/bky070 · Cited by 3
“The cutoff concentrations used for the blood and urine ELISA analysis are listed in Table I and are compared to the 2017 recommendations for DUID testing (14).”
MethodKunsman, G. W., & Hartman, R. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-42917-1_2 · Cited by 3
Everything Is Bigger in Texas: Alcohol Impaired Driving in Houston (2014–2018)
Rodgers, C., Lloyd, M., Stout, P. R., & Lee, D. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa128 · Cited by 3
Meneses, V. M., & Mata, D. C. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab028 · Cited by 2
Huang, C., Tsai, I., Lin, W., Wang, R., Chuang, J. P.-C., Lee, C. W., & Lin, C. (2022) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-021-00745-2 · Cited by 2
“Drug use is related to an increased risk of fatal RTAs, particularly when combined with alcohol consumption (Gadegbeku et al., 2011; Li et al., 2013; Logan et al., 2018; Martin et al., 2017; Papalimperi et al., 2019; Romano et al., 2014).”
BackgroundAyala, J., & Kerrigan, S. (2025) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaf054 · Cited by 2
Self-citationNew psychoactive substances in roadway crash victims in California
Gerona, R. R. L., Tomer, D., Nielsen, D. S., Sage, A. C., French, D., Tolles, J., & Chenoweth, J. (2025) · Frontiers in Toxicology · doi:10.3389/ftox.2025.1572324 · Cited by 2
Smith, M. L. (2020) · Principles of Forensic Toxicology · doi:10.1007/978-3-030-42917-1_13 · Cited by 1
Oxycodone in Forensic Toxicology : Analytical Strategies and Interpretation
Jakobsson, G. (2022) · Linköping University medical dissertations · doi:10.3384/9789179293338 · Cited by 1
Ayala, J., & Kerrigan, S. (2024) · Journal of Analytical Toxicology · doi:10.1093/jat/bkae057 · Cited by 1
Self-citationPoulsen, H., Raymond, O., & McCarthy, M. J. (2024) · Traffic Injury Prevention · doi:10.1080/15389588.2024.2418361 · Cited by 1
“However, reports have highlighted additional drugs of concern, such as anticonvulsants, antipsychotics, and antidepressants (Steuer et al. 2016; Logan et al. 2018), drugs that would not be detected by restricted testing regimes.”
An Unusually High Cocaine Blood Concentration in an Impaired Driving Investigation
Stypa, M. P., & Laythorpe, M. G. (2018) · Journal of Forensic Sciences · doi:10.1111/1556-4029.13925 · Cited by 1
Giorgetti, A., Giorgetti, R., & Basile, G. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_119 · Cited by 1
Alcohol and Drug Testing in Motor Vehicle Crashes
French, D., & Gerona, R. R. L. (2025) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2025.01.017 · Cited by 1
Metabolism and Analysis of Desomorphine
Winborn, J. N. (2018)
Surface-Enhanced Raman Spectroscopy for Cocaine Detection
Mead, K. J. (2020) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/89dd-j8v8
Lee, D. (2020) · Springer eBooks · doi:10.1007/978-3-030-42917-1_38
Giorgetti, A., Giorgetti, R., & Basile, G. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_119-1
Effects of Illegal Drugs on Fitness to Drive
Mußhoff, F., & Fels, H. (2022) · Wiley eBooks · doi:10.1002/9781119648628.ch60
Use of Cannabis and Alcohol by patients diagnosed with trauma in a Health Emergency Unit
de Oliveira, K. O., Sakurada, J. Y., Scanferla, D. T. P., Madia, M. A. O., Lini, R. S., Guedes, M. R. J., Bando, É., de Oliveira, M. L. F., Teixeira, J. J. V., & Mossini, S. A. G. (2022) · Research Society and Development · doi:10.33448/rsd-v11i14.36243
A Case Study on the Integration of Cannabis Law Enforcement in New Jersey
Knezek, C. M., Dudzik, C. G., Gemmellaro, M. D., James, R., Schock, N., & Teasdale, B. W. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5652-1.ch013
Peterson, B. L., & Hessler, M. R. (2025) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaf052
Tsai, J.-H., Yang, Y.-H., Ho, P.-S., Wu, T.-N., Guo, Y. L., Chen, P.-C., & Chuang, H.-Y. (2022) · doi:10.3389/fpubh.2022.849547.s002
Metadata
- Authors
- Logan, B. K., D’Orazio, A. L., Mohr, A. L. A., Limoges, J. F., Miles, A. K., Scarneo, C. E., Kerrigan, S., Liddicoat, L. J., Scott, K. S., & Huestis, M. A.
- Affiliations
- Fredric Rieders Family Foundation (US)
- New York City Police Department (US)
- Wisconsin State Laboratory of Hygiene, 2601 Agriculture Drive, PO Box 7996, Madison, WI 53707-7996, USA
- New Hampshire Department of Safety, Division of State Police Forensic Laboratory, 33 Hazen Drive, Concord, NH 03305, USA
- Sam Houston State University (US)
- Arcadia University (US)
- University of Maryland, Baltimore (US)
- Corresponding author
- Logan, Barry K
- ORCID
- Venue
- Journal of Analytical Toxicology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-11-23
- Volume
- 42
- Issue
- 2
- Pages
- 63-68
- ISSN
- 0146-4760 (ISSN-L)
- 1945-2403
- OpenAlex
- W2770985891
- Semantic Scholar
- 42f69c765005e038ac02e0159690f125474c550d
- Cited by
- 78
- References
- 8
- Citations by year
- 2025: 8 · 2024: 6 · 2023: 7 · 2022: 12 · 2021: 8 · 2020: 15 · 2019: 11 · 2018: 10 · 2017: 1
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Analytical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Justice
- Washington State University
- Rhode Island Department of Health
- National Science Council
- College of Engineering, Michigan State University
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Physical Sciences › Engineering › Safety, Risk, Reliability and Quality › Traffic and Road Safety
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- drug-impaired driving, traffic fatalities, toxicological investigation, forensic toxicology, oral fluid testing, fentanyl, buprenorphine, tramadol, fentanyl analogs, butalbital, phenobarbital, phencyclidine, mitragynine, atypical antipsychotics, expert consensus recommendations
- MeSH terms
- Accidents, Traffic, Driving Under the Influence, Canada, Humans, Illicit Drugs, Substance Abuse Detection, Guidelines as Topic, Forensic Toxicology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.